(Q48828273)

15 February 2018

title

The soluble form of Fas molecule is elevated in parkinsonian brain tissues. (English)

1 reference

15 February 2018

1 reference

1 reference

Mogi M

1

1 reference

15 February 2018

Harada M

2

1 reference

15 February 2018

Kondo T

3

1 reference

15 February 2018

Mizuno Y

4

1 reference

15 February 2018

Narabayashi H

5

1 reference

15 February 2018

Riederer P

6

1 reference

15 February 2018

Nagatsu T

7

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 December 1996

1 reference

15 February 2018

published in

Neuroscience Letters

1 reference

15 February 2018

volume

220

1 reference

15 February 2018

page(s)

195-198

1 reference

15 February 2018

issue

3

1 reference

15 February 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

Fas antigen mRNA induction in postischemic murine brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

1 reference

7 January 2021

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2896%2913257-2

7 January 2021

10.1016/S0304-3940(96)13257-2

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

8994226

1 reference

15 February 2018